---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-26-003124"
form_type: "8-K"
ticker: "ACON"
cik: "0001635077"
company_name: "Aclarion, Inc."
filed_at: "2026-04-22T23:59:59+00:00"
generated_at: "2026-05-15T04:54:03.696703+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Aclarion authorizes $2.5 million share repurchase program over 12 months

## Summary
- Board authorized repurchase of up to $2.5M in common stock over next 12 months.
- CEO Brent Ness says current valuation does not reflect full strength of Nociscan platform.
- Company had $19.0M cash as of March 31, 2026; repurchase funded from existing cash.
- Program may be executed via open market purchases, block trades, 10b5-1 plans, or private deals.
- Management believes cash runway supports milestones including CLARITY trial initial milestone.

## SEC filing metadata
- accession: 0001683168-26-003124
- form_type: 8-K
- ticker: ACON
- cik: 0001635077
- company_name: Aclarion, Inc.
- filed_at: 2026-04-22T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1635077/000168316826003124/0001683168-26-003124-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1635077/000168316826003124/aclarion_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-26-003124
- JSON: https://secwatch.observer/filing/0001683168-26-003124.json
- Plain text: https://secwatch.observer/filing/0001683168-26-003124.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.